Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Depreciation & Amortization (CF) (2016 - 2025)

Healthstream (HSTM) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $11.0 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 5.48% to $11.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.5 million through Dec 2025, up 5.42% year-over-year, with the annual reading at $43.5 million for FY2025, 5.42% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $11.0 million at Healthstream, up from $10.8 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $11.0 million in Q4 2025, with the low at $9.1 million in Q3 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $10.0 million, with a median of $10.1 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) grew 27.96% in 2021, then fell 3.17% in 2024.
  • Over 5 years, Depreciation & Amortization (CF) stood at $9.4 million in 2021, then increased by 2.57% to $9.6 million in 2022, then rose by 9.52% to $10.5 million in 2023, then decreased by 0.59% to $10.5 million in 2024, then rose by 5.48% to $11.0 million in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $11.0 million, $10.8 million, and $10.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.